Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Cash from Operations: 2017-2024

Historic Cash from Operations for Bicycle Therapeutics (BCYC) over the last 8 years, with Dec 2024 value amounting to -$164.7 million.

  • Bicycle Therapeutics' Cash from Operations fell 78.68% to -$71.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$239.7 million, marking a year-over-year decrease of 18.31%. This contributed to the annual value of -$164.7 million for FY2024, which is 171.70% down from last year.
  • According to the latest figures from FY2024, Bicycle Therapeutics' Cash from Operations is -$164.7 million, which was down 171.70% from -$60.6 million recorded in FY2023.
  • Over the past 5 years, Bicycle Therapeutics' Cash from Operations peaked at -$14.8 million during FY2021, and registered a low of -$164.7 million during FY2024.
  • Over the past 3 years, Bicycle Therapeutics' median Cash from Operations value was -$86.1 million (recorded in 2022), while the average stood at -$103.8 million.
  • Per our database at Business Quant, Bicycle Therapeutics' Cash from Operations soared by 37.83% in 2020 and then slumped by 482.07% in 2022.
  • Bicycle Therapeutics' Cash from Operations (Yearly) stood at -$17.8 million in 2020, then climbed by 16.84% to -$14.8 million in 2021, then plummeted by 482.07% to -$86.1 million in 2022, then increased by 29.59% to -$60.6 million in 2023, then slumped by 171.70% to -$164.7 million in 2024.